C
C.J.A. Punt
Researcher at University of Amsterdam
Publications - 45
Citations - 3708
C.J.A. Punt is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Colorectal cancer & Medicine. The author has an hindex of 16, co-authored 34 publications receiving 2782 citations. Previous affiliations of C.J.A. Punt include Utrecht University.
Papers
More filters
Journal ArticleDOI
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E. Van Cutsem,Andrés Cervantes,René Adam,Alberto Sobrero,J.H.J.M. van Krieken,Dan Aderka,E. Aranda Aguilar,Alberto Bardelli,Al B. Benson,György Bodoky,Fortunato Ciardiello,André D'Hoore,Eduardo Díaz-Rubio,J.-Y. Douillard,Michel Ducreux,Alfredo Falcone,Axel Grothey,Thomas Gruenberger,Karin Haustermans,Volker Heinemann,Paulo M. Hoff,C.-H. Köhne,R. Labianca,Pierre Laurent-Puig,Brigette B.Y. Ma,Tim Maughan,Kei Muro,Nicola Normanno,Pia Österlund,Pia Österlund,Wim J.G. Oyen,Demetris Papamichael,George Pentheroudakis,Per Pfeiffer,Timothy J. Price,C.J.A. Punt,Jens Ricke,Arnaud Roth,R. Salazar,Werner Scheithauer,H.-J. Schmoll,Josep Tabernero,Julien Taieb,Sabine Tejpar,Harpreet Wasan,Takayuki Yoshino,Aziz Zaanan,Dirk Arnold +47 more
TL;DR: These ESMO consensus guidelines have been developed based on the current available evidence to provide a series of evidence-based recommendations to assist in the treatment and management of patients with mCRC in this rapidly evolving treatment setting.
Journal ArticleDOI
Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer
D A M Sloothaak,D. E. Geijsen,N.J. van Leersum,C.J.A. Punt,Christianne J. Buskens,W. A. Bemelman,Pieter J. Tanis +6 more
TL;DR: The purpose of this study was to analyse the influence of variations in clinical practice regarding timing of surgery on pathological response at a population level.
Journal ArticleDOI
Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983.
Erik Tanis,Bernard Nordlinger,Murielle Mauer,Halfdan Sorbye,F. van Coevorden,Thomas Gruenberger,Peter M. Schlag,C.J.A. Punt,Jonathan A. Ledermann,Theo J.M. Ruers +9 more
TL;DR: This study supports the local control of RFA in patients with limited liver metastases and should evaluate in which patients RFA could be an equal alternative to liver resection.
Journal ArticleDOI
6010 POSTER DISCUSSION Radiofrequency Ablation Combined With Systemic Treatment Versus Systemic Treatment Alone in Patients With Non- Resectable Colorectal Liver Metastases: a Randomized EORTC Intergroup Phase II Study (EORTC 40004)
T.J.M. Ruers,C.J.A. Punt,F. van Coevorden,Jonathan A. Ledermann,G. Poston,Wolf O. Bechstein,M.A. Lentz,M. Mauei,Manfred P. Lutz,Bernard Nordlinger +9 more
TL;DR: This is the first randomized study on the efficacy of RFA and the study met the primary end point on 30-month OS; however, the results in the control arm were in the same range.
Journal ArticleDOI
Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer.
Amanda C.R.K. Bos,F.N. van Erning,Y.R.B.M. van Gestel,G.J.M. Creemers,C.J.A. Punt,M. G. H. van Oijen,Valery E.P.P. Lemmens +6 more
TL;DR: The data support initiating adjuvant chemotherapy in stage III colon cancer patients within 8 weeks post-surgery, and factors associated with starting treatment after 8 weeks were older age and prolonged postoperative hospital admission.